As a component of high-density lipoprotein, APOA5 is also associated with lipid-related diseases such as hypertriglyceridemia 1 and hyperlipoproteinemia type V (Johansen et al., 2010; Mendoza-Barbera et al., 2013). This evidence concerns the gene APOA5 and Hyperlipoproteinemia type 4.